Mouse TNFRSF9/4-1BB PicoKine ELISA Kit

Mouse TNFRSF9/4-1BB PicoKine ELISA Kit 

To Order Contact us: [email protected]

TNFRSF9/4-1BB (Human) ELISA Kit
K4238-100 each
EUR 966

ELISA kit for Human TNFRSF9/4-1BB
EK5461 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human TNFRSF9/4-1BB in samples from serum, plasma, tissue homogenates and other biological fluids.

4-1BB / TNFRSF9 Recombinant Protein
11-142 0.1 mg
EUR 714.3
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

4-1BB / TNFRSF9 Recombinant Protein
11-149 0.1 mg
EUR 714.3
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

4-1BB / TNFRSF9 Recombinant Protein
11-324 0.1 mg
EUR 714.3
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

4-1BB / TNFRSF9 Recombinant Protein
11-497 0.1 mg
EUR 651.3
Description: 4-1BB is also known as CD137, tumor necrosis factor receptor superfamily member 9 (TNFRSF9), induced by lymphocyte activation (ILA), is a co-stimulatory molecule of the tumor necrosis factor (TNF) receptor superfamily. CD137 can be expressed by activated T cells, but to a larger extent on CD8 than on CD4 T cells. In addition, CD137 expression is found on dendritic cells, follicular dendritic cells, natural killer cells, granulocytes and cells of blood vessel walls at sites of inflammation. The best characterized activity of CD137 is its costimulatory activity for activated T cells. Crosslinking of CD137 enhances T cell proliferation, IL-2 secretion survival and cytolytic activity. Further, it can enhance immune activity to eliminate tumors in mice. CD137 can enhance activation-induced T cell apoptosis when triggered by engagement of the TCR/CD3 complex. In addition, 4-1BB/4-1BBL co-stimulatory pathway has been shown to augment secondary CTL responses to several viruses, and meanwhile augment anti-tumor immunity. 4-1BB thus is a promising candidate for immunotherapy of human cancer. CD137 has been shown to interact with TRAF2.

4-1BB Receptor, TNFRSF9, human
RC214-25R 5ug
EUR 125.26

Recombinant 4-1BB / TNFRSF9 Protein
VAng-2776Lsx-1mg 1 mg
EUR 7252.8
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: Q07011)

Recombinant 4-1BB / TNFRSF9 Protein
VAng-2776Lsx-20g 20 µg
EUR 786
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: Q07011)

CD137 Antibody / 4-1BB / TNFRSF9
V8353-100UG 100 ug
EUR 499
Description: CD137 (4-1BB), a member of the tumor necrosis factor receptor superfamily, is a type I transmembrane glycoprotein expressed on the cell surface of activated splenic T cells and thymocytes. The functions of CD137 in T lymphocytes include regulating activation, proliferation and apoptosis. CD137 and CD28 are costimulatory molecules of T cell activation. Costimulatory molecules are important in initiating anti-tumor immune responses. CD137 plays an important role in regulating T-cell-dependent immune responses. Expression of CD137 correlates negatively with lymphocyte proliferation and positively with the degree of activation-induced cell death caused by mitogen overstimulation. In monocytes, CD137 induces activation, promotes adherence and prolongs survival. The LOB12.3 antibody is an agonistic antibody that has been shown to stimulate 4-1BB signaling and delay tumor growthin vivowhen administered in combination with immune checkpoint inhibitors.

CD137 Antibody / 4-1BB / TNFRSF9
V8353-20UG 20 ug
EUR 219
Description: CD137 (4-1BB), a member of the tumor necrosis factor receptor superfamily, is a type I transmembrane glycoprotein expressed on the cell surface of activated splenic T cells and thymocytes. The functions of CD137 in T lymphocytes include regulating activation, proliferation and apoptosis. CD137 and CD28 are costimulatory molecules of T cell activation. Costimulatory molecules are important in initiating anti-tumor immune responses. CD137 plays an important role in regulating T-cell-dependent immune responses. Expression of CD137 correlates negatively with lymphocyte proliferation and positively with the degree of activation-induced cell death caused by mitogen overstimulation. In monocytes, CD137 induces activation, promotes adherence and prolongs survival. The LOB12.3 antibody is an agonistic antibody that has been shown to stimulate 4-1BB signaling and delay tumor growthin vivowhen administered in combination with immune checkpoint inhibitors.

CD137 Antibody / 4-1BB / TNFRSF9
V8353SAF-100UG 100 ug
EUR 499
Description: CD137 (4-1BB), a member of the tumor necrosis factor receptor superfamily, is a type I transmembrane glycoprotein expressed on the cell surface of activated splenic T cells and thymocytes. The functions of CD137 in T lymphocytes include regulating activation, proliferation and apoptosis. CD137 and CD28 are costimulatory molecules of T cell activation. Costimulatory molecules are important in initiating anti-tumor immune responses. CD137 plays an important role in regulating T-cell-dependent immune responses. Expression of CD137 correlates negatively with lymphocyte proliferation and positively with the degree of activation-induced cell death caused by mitogen overstimulation. In monocytes, CD137 induces activation, promotes adherence and prolongs survival. The LOB12.3 antibody is an agonistic antibody that has been shown to stimulate 4-1BB signaling and delay tumor growthin vivowhen administered in combination with immune checkpoint inhibitors.

CD137 Antibody / 4-1BB / TNFRSF9
V8636-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V8636-20UG 20 ug
EUR 219
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V8636SAF-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7531-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7531-20UG 20 ug
EUR 219
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7531IHC-7ML 7 ml
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7531SAF-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7567-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7567-20UG 20 ug
EUR 219
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7567BTN 500 ul
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7567IHC-7ML 7 ml
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V7567SAF-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V8061-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V8061-20UG 20 ug
EUR 219
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

CD137 Antibody / 4-1BB / TNFRSF9
V8061SAF-100UG 100 ug
EUR 499
Description: CD137 belongs to the tumor necrosis factor receptor family and delivers a costimulatory signal to T lymphocytes. It is expressed on activated T cells and binds an inducible ligand that is found on B cells, macrophages and dendritic cells. Interactions between CD137 and its ligand are involved in antigen presentation and the generation of cytotoxic T cells. CD137 antibody may improve cancer treatment, and has been implicated in breast cancer, melanoma and lymphoma.

Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc)
CI69-10ug 10ug
EUR 169.2
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc)
CI69-1mg 1mg
EUR 2008.8
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc)
CI69-500ug 500ug
EUR 1338
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Mouse 4-1BB/TNFRSF9/CD137 (C-Fc)
CI69-50ug 50ug
EUR 363.6
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 Protein
RP00466 10 μg
EUR 186

Recombinant 4-1BB / TNFRSF9 Protein (CHO cells)
VAng-2782Lsx-200g 200 µg
EUR 2518.8
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in CHO cells. (Uniprot ID: Q07011)

Recombinant 4-1BB / TNFRSF9 Protein (Baculovirus) [His]
VAng-2786Lsx-250g 250 µg
EUR 3112.8
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Baculovirus. (Uniprot ID: Q07011)

Recombinant 4-1BB / TNFRSF9 Protein (Baculovirus) [His]
VAng-2786Lsx-50g 50 µg
EUR 1083.6
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in Baculovirus. (Uniprot ID: Q07011)

Human CellExp? 4-1BB / TNFRSF9, Human recombinant
9227-10 each
EUR 320.4

Human CellExp? 4-1BB / TNFRSF9, Human recombinant
9227-50 each
EUR 855.6

TNFRSF9/4-1BB ELISA Kit| Mouse Tumor necrosis factor receptor su
EF012924 96 Tests
EUR 826.8

Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-256)
VAng-2778Lsx-100g 100 µg
EUR 7599.6
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in cell free expression systems. (Uniprot ID: P20334)

Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-256)
VAng-2778Lsx-50g 50 µg
EUR 4546.8
Description: Recombinant 4-1BB / TNFRSF9 Protein was expressed in cell free expression systems. (Uniprot ID: P20334)

Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187)
VAng-2781Lsx-100g 100 µg
EUR 1116
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334)

Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187)
VAng-2781Lsx-1mg 1 mg
EUR 4134
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334)

Recombinant Mouse 4-1BB / TNFRSF9 Protein (aa 24-187)
VAng-2781Lsx-500g 500 µg
EUR 2700
Description: Recombinant mouse 4-1BB / TNFRSF9 Protein was expressed in E. coli. (Uniprot ID: P20334)

Recombinant Human 4-1BB Receptor Protein
PROTQ07011-4 20ug
EUR 380.4
Description: 4-1BB Receptor, a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells. The human 4-1BB Receptor gene codes for a 255 amino acid type I transmembrane protein containing a 17 amino acid N-terminal signal sequence, a 169 amino acid extracellular domain, a 27 amino acid transmembrane domain and a 42 amino acid cytoplasmic domain. Recombinant human soluble 4-1BB Receptor is a 167 amino acid polypeptide (17.7 kDa), which contains the cysteine rich TNFR-like extracellular domain of 4-1BB Receptor.

Mouse TNFRSF9/4-1BB EZ-Set™ ELISA Kit (DIY Antibody Pairs)
EZ1143 5 plates/kit
EUR 370.8
Description: For the development of sandwich ELISA kit to measure mouse TNFRSF9/4-1BB in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA).

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His)
CB18-10ug 10ug
EUR 151.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His)
CB18-1mg 1mg
EUR 1521.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His)
CB18-500ug 500ug
EUR 1082.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-6His)
CB18-50ug 50ug
EUR 272.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc)
CB19-10ug 10ug
EUR 151.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc)
CB19-1mg 1mg
EUR 1521.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc)
CB19-500ug 500ug
EUR 1082.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Cynomolgus 4-1BB/TNFRSF9/CD137 (C-Fc)
CB19-50ug 50ug
EUR 272.4
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC)
CW21-10ug 10ug
EUR 175.2
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC)
CW21-1mg 1mg
EUR 2739.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC)
CW21-500ug 500ug
EUR 1935.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 (C-mFC)
CW21-50ug 50ug
EUR 363.6
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Recombinant Human 4-1BB/TNFRSF9/CD137 (C-6His)
CP05-10ug 10ug
EUR 96
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4.

Mouse TNFRSF9/4-1BB PicoKine ELISA Kit